Kimberly Clark 39320.00

Kimberly Clark 39320.00

Started: 9/2019 Study name: A longitudinal study to evaluate various skin health biophysical measures preceding diaper dermatitis in newborns Indication: None Specified Skin Study Principal Investigator:  Amy Bargen
Kimberly Clark 39320.00

Kimberly Clark 39322.00

Started: 9/2019 Study Name: An exploratory study to identify the composition of the microbiome of healthy diapered skin in eight to twelve month old infants. Indication: None Specified Skin Study Principal Investigator: Amy Bargen
Pfizer C3671003

Pfizer C3671003

Started: 9/2019 Study Name A phase 2b, randomized, placebo-controlled, observer-blinded trial to evaluate the safety, tolerability, and immunogenicity of a respiratory syncytial virus (rsv) vaccine in pregnant women 18 through 49years of age and their infants...
GSK ROTA-96

GSK ROTA-96

Started: 6/2019 Study Name: A phase III, observer-blind, randomized, multi-country study to assess the  reactogenicity and safety of the Porcine circovirus (PCV) free liquid formulation of GSK’s oral live attenuated human rotavirus (HRV) vaccine as compared to the xxx...
Merck V114-029

Merck V114-029

Started: 9/2018 Study Name: A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4-dose Regimen of V114 in Healthy Infants (PNEU-PED) Indication: Pneumococcal Principal...